Do Analysts Agree Wednesday on Aadi Bioscience Inc (AADI) Stock's Target Price?

Wednesday, January 19, 2022 03:00 PM | InvestorsObserver Analysts

Mentioned in this article

Wall Street is positive on Aadi Bioscience Inc (AADI). On average, analysts give the stock a Strong Buy rating. The average price target is $50, which means analysts expect the stock to increase by 141.20% over the next twelve months. That average ranking earns the stock an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating AADI a Strong Buy today. Find out what this means to you and get the rest of the rankings on AADI!
See Full AADI Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Aadi Bioscience Inc Stock Today?

Aadi Bioscience Inc (AADI) stock is trading at $20.73 as of 2:57 PM on Wednesday, Jan 19, a loss of -$1.19, or -5.43% from the previous closing price of $21.92. The stock has traded between $20.24 and $21.90 so far today. Volume today is 237,299 compared to average volume of 200,389. Click Here to get the full Stock Report for Aadi Bioscience Inc stock.

Share this article:

Related Articles